Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Terms of Use
Privacy Policy
Sitemap
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Hematologic Malignancies
•
Medical Oncology
•
Lymphoma
•
Hematology
How do you treat ALK+ large B cell lymphoma in a young fit patient?
Related Questions
How do you choose bridging therapy prior to CAR-T leukapheresis?
How will you use Pola-R-CHP in the frontline treatment of DLBCL?
What frontline regimen would you use for a patient with double-hit lymphoma and compensated systolic cardiac dysfunction?
How do you utilize ibrutinib + R-CHOP in the frontline treatment of DLBCL?
When is a bone marrow biopsy indicated in the workup of diffuse large B cell lymphoma?
Do you routinely offer antiviral prophylaxis for patients receiving chemoimmunotherapy?
How long do you give systemic therapies or skin directed therapies to work before changing treatments in patients with diffuse skin limited mycoses fungoides?
How would you treat a fit patient with a history of relapsed CLL who now presents with Richter transformation s/p autologous anti-CD19 chimeric antigen receptor (CAR) T-cells?
Do you avoid using tafasitamab in germinal center subtype diffuse large B-cell lymphoma?
What salvage chemotherapy, if any, would you recommend for a patient with primary refractory DLBCL who progressed after two cycles of R-CHOP?
